Insect diversity, community composition and damage index on wild and cultivated murtilla

Plant domestication is a process in which plants’ chemical defenses that help them cope with herbivores might decline. Consequences of this process could be reflected in an increase in insect pests. Therefore, we carried out a survey to contrast the diversity, damage indexes and insect assemblages between cultivated and wild "Murtilla" (Ugni molinae) plants. The main scientific question put forward in this paper is as follows: Is there a decrease in diversity and an increase in both insect assemblages and damage indexes associated with the domestication process in U. molinae plants? The objective of this report was to compare the structure of a taxonomic assemblage collected in both wild and cultivated plants and their temporal variation over the year. Seven ecotypes and their respective wild populations were selected for these studies. The results showed higher insect assemblages in wild parents (77.35%) vs. cultivated (22.7%). The damage indexes were also higher in wild plants (0.23). The diversity indexes according to Margalef (12.98), the Shannon index (5.15) and the Simpson index (19.04) were higher in wild plants. Moreover, approximately 60 species were determínate. We detected changes in insect assemblages, damage and diversity indexes that could suggest that murtilla domestication has altered insect assemblages.M. Chacón-Fuentes, M. Lizama, L. Parra, I Seguel y A. Quiroz. 2016. Diversidad, composición de la comunidad de insectos e índice de daño, en murtillas silvestres y cultivadas. Cien. Inv. Agr. 43(1):57-67. La domesticación vegetal es un proceso en el cual las plantas pueden disminuir su nivel de defensas químicas para combatir herbívoros. Algunas de las posibles consecuencias podrían reflejarse en un incremento en el número y en la diversidad de insectos. Por lo tanto, se realizó un "survey" para comparar el índice de daño y la diversidad de insectos en plantas cultivadas y silvestres de murtilla (Ugni molinae). La principal interrogante de este trabajo fue: ¿La domesticación en plantas de murtilla, disminuirá la diversidad e incrementará el índice de daño y la comunidad de insectos? El objetivo de esta investigación fue comparar la población de insectos asociada a plantas silvestres y cultivadas además de analizar su variación durante el año. Siete ecotipos y sus correspondientes contrapartes silvestres fueron seleccionadas para este estudio. Los resultados mostraron un mayor número de insectos en plantas silvestres (77,35%) vs. (22,7%) cultivadas. El índice de daño fue mayor en plantas silvestres (0,23) comparada con plantas cultivadas. El índice de Margalef mostró la mayor riqueza de insectos en plantas cultivadas. Sin embargo, el índice de Shannon fue mayor (5.15) en plantas silvestres. Además, cerca de 60 especies de insectos fueron determinadas. Se detectaron cambios en la comunidad de insectos, índices de daño y diversidad que podrían sugerir que la domesticación en murtilla ha alterado la comunidad de insectos

Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.

Uptake through the dopamine transporter (DAT) represents the primary mechanism used to terminate dopaminergic transmission in brain. Although it is well known that dopamine (DA) taken up by the transporter is used to replenish synaptic vesicle stores for subsequent release, the molecular details of this mechanism are not completely understood. Here, we identified the synaptic vesicle protein synaptogyrin-3 as a DAT interacting protein using the split ubiquitin system. This interaction was confirmed through coimmunoprecipitation experiments using heterologous cell lines and mouse brain. DAT and synaptogyrin-3 colocalized at presynaptic terminals from mouse striatum. Using fluorescence resonance energy transfer microscopy, we show that both proteins interact in live neurons. Pull-down assays with GST (glutathione S-transferase) proteins revealed that the cytoplasmic N termini of both DAT and synaptogyrin-3 are sufficient for this interaction. Furthermore, the N terminus of DAT is capable of binding purified synaptic vesicles from brain tissue. Functional assays revealed that synaptogyrin-3 expression correlated with DAT activity in PC12 and MN9D cells, but not in the non-neuronal HEK-293 cells. These changes were not attributed to changes in transporter cell surface levels or to direct effect of the protein-protein interaction. Instead, the synaptogyrin-3 effect on DAT activity was abolished in the presence of the vesicular monoamine transporter-2 (VMAT2) inhibitor reserpine, suggesting a dependence on the vesicular DA storage system. Finally, we provide evidence for a biochemical complex involving DAT, synaptogyrin-3, and VMAT2. Collectively, our data identify a novel interaction between DAT and synaptogyrin-3 and suggest a physical and functional link between DAT and the vesicular DA system

Long-term surveillance of the feline leukemia virus in the endangered Iberian lynx (Lynx pardinus) in Andalusia, Spain (2008-2021)

Feline leukemia virus (FeLV) infection is considered one of the most serious disease threats for the endangered Iberian lynx (Lynx pardinus) Over 14 years (2008-2021), we investigated FeLV infection using point-of-care antigen test and quantitative real-time TaqMan qPCR for provirus detection in blood and tissues in lynxes from Andalusia (Southern Spain). A total of 776 samples from 586 individuals were included in this study. The overall prevalence for FeLV antigen in blood/serum samples was 1.4% (5/360) (95% CI: 0.2-2.6), FeLV proviral DNA prevalence in blood samples was 6.2% (31/503) (95% CI: 4.1-8.6), and FeLV proviral DNA in tissues samples was 10.2% (34/333) (95% CI: 7-13.5). From a subset of 129 longitudinally sampled individuals, 9.3% (12/129) PCR-converted during the study period. Our results suggest that FeLV infection in the Andalusian population is enzootic, with circulation of the virus at low levels in almost all the sampling years. Moreover, since only one viremic individual succumbed to the infection, this study suggests that lynxes may therefore control the infection decreasing the possibility of developing a more aggressive outcome. Although our results indicate that the FeLV infection in the Iberian lynx from Andalusia tends to stay within the regressive stage, continuous FeLV surveillance is paramount to predict potential outbreaks and ensure the survival of this population

Cien días vistos por CINEP (no. 88 jun-ago 2016)

En esta edición de la revista Cien Días, se presenta un análsis sobre el acuerdo de paz firmado por el presidente Juan Manuel Santos y las FACR-EP, desde la perspectiva del trabajo que realiza CINEP/PPP. Así, ´el acumulado de investigación de esta organización sobre el origen y la evolución del conflicto armado colombiano, el proceso regional de configuración del Estado, la importancia de las luchas sociales en una sociedad democrática, la plena vigencia de los derechos humanos y la movilización social por la paz, así como la experiencia en educación y acompañamiento a comunidades y organizaciones, es compatible con aquello que está recogido en el texto del acuerdo.´Editorial ¿Por qué Cinep/PPP dice Sí a la Paz? ......... 3 Por: Cinep - Programa por la Paz Acuerdos de paz Cese al fuego en perspectiva civil ................ 5 Por: Fernando Sarmiento Santander. Los derechos de las víctimas en el acuerdo de La Habana (Cuba) ................... 10 Por: Ángela Ballesteros G. y Jerry de J. Garavito R. Innovaciones del proceso de paz en Colombia (infografía)........................... 18 Por: Kristian Herbolzheimer. Tierras Segundos ocupantes en la restitución de tierras ................................................... 20 Por: Andrea Lopera. Movimientos sociales Luchas de trabajadores de la salud............ 30 Por: Leonardo Parra y Gissell Medina. Seguridad El ilusionismo de la paz .............................. 36 Por: William Rozo. Proceso con el ELN Proceso de paz ELN-Gobierno, un enfermo crítico, pero no terminal ............................ 42 Por: Julián Barajas

Implantación de un registro específico de reacciones adversas a ferroterapia endovenosa ambulatoria en un hospital de tercer nivel

Poster [PC-118] Introducción: La Agencia Española de medicamentos y productos sanitarios (AEMPS) estableció en 2013 nuevas recomendaciones para la administración intravenosa de preparados de hierro tras la notificación de reacciones de hipersensibilidad. Aunque estos preparados mantienen un balance beneficio-riesgo favorable se deben establecer medidas específicas para la identificación temprana y el tratamiento inmediato de las reacciones alérgicas. Pacientes y Métodos: Implantación de medidas de seguridad en la vigilancia de la administración intravenosa de preparados de hierro cumpliendo los tiempos de observación recomendados por la AEMPS. Elaboración de un formulario de reacciones adversas específico para la administración de ferroterapia endovenosa, de fácil cumplimentación por el personal de Enfermería del hospital de Día de Hematología del Hospital Universitario Miguel Servet. Análisis de la incidencia de reacciones adversas en relación con la ferroterapia prescrita desde la consulta de Eritropatología a pacientes con anemia ferropénica. Estudio descriptivo y prospectivo realizado en un periodo de 4 meses (Enero 2018 – Mayo 2018). Análisis de las reacciones adversas detectadas en relación al tratamiento con hierro endovenoso disponible en nuestro centro en diferentes posologías: hierro-sacarosa (Venofer®) 200 mg, hierro-carboximaltosa (Ferinject®) 500 mg y 1 gr. Resultados: Se han estudiado 77 pacientes. 52 hombres y 25 mujeres. La mediana de edad fue 68 años. 21 (27, 27%) pacientes tenían alergias o intolerancias conocidas previamente. 53 (68, 83%) recibieron tratamiento con hierro sacarosa (200mg) y 24 (31, 17%) con hierro carboximaltosa [20 (83, 83%) 500mg, 4 (16, 67%) 1g]. Todos los pacientes cumplieron los tiempos de vigilancia recomendados por la AEMPS. Únicamente dos pacientes presentaron reacciones adversas al hierro y ambos con dosis de 200mg de hierro sacarosa. Los dos presentaron reacciones gastrointestinales leves de duración autolimitada de unos 15 minutos, sin repercusión orgánica y sin precisar medicación para su resolución. Conclusiones: Las reacciones graves de hipersensibilidad al hierro endovenoso son, como en nuestra serie de casos, efectos adversos muy poco frecuentes. A diferencia de los casos descritos de reacciones graves anafilácticas, en nuestro centro no hemos detectado ninguna gravedad en todos los tratamientos administrados. Tampoco hemos podido relacionar las dos reacciones leves detectadas con predisposición previa de los pacientes al desarrollo de alergias medicamentosas u otras intolerancias, ni tampoco con la dosis de hierro o preparado administrado. Dada la alerta de la AEMPS, nuestro registro específico de reacciones adversas a ferroterapia endovenosa nos permite estar alerta y constatar de manera objetiva la existencia o no de dichas reacciones así como su gravedad

Etnometodología para la comprensión y el manejo de la Enfermedad de Chagas en las poblaciones indígenas Wiwa asentadas en la vertiente suroriental de la Sierra Nevada de Santa Marta

El objetivo de este trabajo fue establecer prevalencia de la Enfermedad de Chagas en las comunidades Wiwa de la Sierra Nevada de Santa Marta trascendiendo el modelo de investigación biomédica sustentado en el paradigma positivista, e involucrando la dimensión sociocultural y ambiental que caracteriza este fenómeno, desde la sostenibilidad como un nuevo paradigma de las ciencias. Se realizó un muestreo probabilístico de las 15 comunidades Wiwa asentadas en la zona de San Juan del César, Departamento de la Guajira, se realizaron los procedimientos biomédicos definidos para investigaciones epidemiológicas, paralelamente se realizaron procedimientos culturales desde el saber tradicional de las comunidades Wiwa, garantizando la armonía de las comunidades ante la agresión biomédica de su espacio ambiental, social y cultural. Se obtuvo una prevalencia de 33.5%, concordante con las cifras de Enfermedad de Chagas encontradas en las otras vertientes de la sierra, reflejando condiciones similares que predisponen a la presencia de la enfermedad. Se estableció como esta enfermedad es inexistente en el sistema médico tradicional de los Wiwa, y sólo el insecto vector es reconocido aunque no considerado como agente perturbador de la salud de las comunidades. A partir de la consideración del vector como eje integrador de las dos culturas se describen las características sociales, ambientales y culturales que definen la Enfermedad de Chagas en los Wiwa y de esta forma, la posibilidad de su comprensión y manejo desde factores complementarios al modelo biomédico.The goal of this research was to establish Chagas Disease prevalence in Wiwa communities of Sierra Nevada de Santa Marta, beyond biomedical research model supported in positivist paradigm, towards sustainability as a new paradigm of science, by which this phenomenon has a social, cultural and environmental dimensions. A probabilistic sample was made it in 15 Wiwa communities placed in San Juan del Cesar area, La Guajira. Biomedical procedures defined from epidemiological research were made them, and simultaneously, cultural procedures derived from ancestral knowledge of Wiwa communities were made them, guarantee harmony in communities against biomedical aggression of environmental, cultural and social dimensions. A 33.5% prevalence of Chagas Disease was obtained, similar to prevalence reported in other sierra's slope with similar conditions related to disease transmission. It was established that chagas disease doesn't exist in Wiwa traditional medical system, and only vector insect is recognized but not considered as a disturbed agent of communities' health. Social, environmental and cultural characteristics that define Chagas disease were described since consideration that vector insect is an integrating axis of two cultures, and in this way, possibilities to comprehension and management of chagas disease, complementing biomedical model, were described too

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

In spite of the advances in immunotherapy and targeted therapies, lung cancer continues to be the leading cause of cancer-related death. The epidermal growth factor receptor is an established target for non-small cell lung cancer (NSCLC), and its overactivation by the ligands can induce accelerated proliferation, angiogenesis, and metastasis as well as proinflammatory or immunosuppressive signals. CIMAvax-EGF is an epidermal growth factor (EGF)-depleting immunotherapy that is approved for the treatment of NSCLC patients in Cuba. The study was designed as a phase IV trial to characterize the safety and effectiveness of CIMAvax-EGF in advanced NSCLC patients treated in 119 community polyclinics and 24 hospitals. CIMAvax-EGF treatment consisted of four bi-weekly doses followed by monthly boosters. Overall, 741 NSCLC patients ineligible for further cancer-specific treatment were enrolled. CIMAvax-EGF was safe, and the most common adverse events consisted of mild-to-moderate injection site reactions, fever, chills, tremors, and headache. For patients completing the loading doses, the median survival was 9.9 months. For individuals achieving at least stable disease to the frontline and completing vaccination induction, the median survival was 12 months. Most of the functional activities and symptoms evaluated through the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire improved over time. In conclusion, this real-world trial demonstrated that CIMAvax-EGF was safe and effective in patients who were vaccinated in the maintenance scenario. A larger effect was seen in subjects with poor prognosis like those with squamous tumors and high EGF levels. Remarkably, this community-based intervention was very important because it demonstrated the feasibility of treating advanced lung cancer patients with active immunotherapy in primary care institutions. In addition to CIMAvax-EGF, patients received supportive care at the community clinic. Vaccine administration by the family doctors at the polyclinics reduced the patients’ burden on the medical oncology services that continued providing chemotherapy and other complex therapies. We conclude that community polyclinics constitute the optimal scenario for administering those cancer vaccines that are safe and require prolonged maintenance in patients with advanced cancer, despite the continuous deterioration of their general condition.Clinical trial registrationhttps://rpcec.sld.cu/trials/RPCEC00000205-En, identifier RPCEC00000205

Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic